Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Risk of Deficiency in Multiple Concurrent Micronutrients in Children and Adults in the United States.

Bird JK, Murphy RA, Ciappio ED, McBurney MI.

Nutrients. 2017 Jun 24;9(7). pii: E655. doi: 10.3390/nu9070655.

2.

Quality-of-Life Outcomes From a Randomized Clinical Trial Comparing Antimetabolites for Intermediate, Posterior, and Panuveitis.

Niemeyer KM, Gonzales JA, Rathinam SR, Babu M, Thundikandy R, Kanakath A, Porco TC, Browne EN, Rao MM, Acharya NR.

Am J Ophthalmol. 2017 Jul;179:10-17. doi: 10.1016/j.ajo.2017.04.003. Epub 2017 Apr 14.

PMID:
28414043
3.

Bivariate Analysis of Age-Related Macular Degeneration Progression Using Genetic Risk Scores.

Ding Y, Liu Y, Yan Q, Fritsche LG, Cook RJ, Clemons T, Ratnapriya R, Klein ML, Abecasis GR, Swaroop A, Chew EY, Weeks DE, Chen W.

Genetics. 2017 May;206(1):119-133. doi: 10.1534/genetics.116.196998. Epub 2017 Mar 24.

PMID:
28341650
4.

Visualization of Dietary Patterns and Their Associations With Age-Related Macular Degeneration.

Chiu CJ, Chang ML, Li T, Gensler G, Taylor A.

Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1404-1410. doi: 10.1167/iovs.16-20454.

5.

Population-based survey of prevalence, causes, and risk factors for blindness and visual impairment in an aging Chinese metropolitan population.

Hu JY, Yan L, Chen YD, Du XH, Li TT, Liu DA, Xu DH, Huang YM, Wu Q.

Int J Ophthalmol. 2017 Jan 18;10(1):140-147. doi: 10.18240/ijo.2017.01.23. eCollection 2017.

6.

Preliminary analysis of the relationship between serum lutein and zeaxanthin levels and macular pigment optical density.

Fujimura S, Ueda K, Nomura Y, Yanagi Y.

Clin Ophthalmol. 2016 Oct 31;10:2149-2155. eCollection 2016.

7.

Homocysteine & its metabolite homocysteine-thiolactone & deficiency of copper in patients with age related macular degeneration - A pilot study.

Bharathselvi M, Biswas S, Raman R, Selvi R, Coral K, Narayanansamy A, Ramakrishnan S, Sulochana KN.

Indian J Med Res. 2016 Jun;143(6):756-762. doi: 10.4103/0971-5916.192026.

8.

CLINICAL ENDPOINTS FOR THE STUDY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION.

Sadda SR, Chakravarthy U, Birch DG, Staurenghi G, Henry EC, Brittain C.

Retina. 2016 Oct;36(10):1806-22. doi: 10.1097/IAE.0000000000001283. Review.

9.

Cellular and Molecular Pathology of Age-Related Macular Degeneration: Potential Role for Proteoglycans.

Al Gwairi O, Thach L, Zheng W, Osman N, Little PJ.

J Ophthalmol. 2016;2016:2913612. doi: 10.1155/2016/2913612. Epub 2016 Aug 1. Review.

10.

Monomeric C-reactive protein and inflammation in age-related macular degeneration.

Chirco KR, Whitmore SS, Wang K, Potempa LA, Halder JA, Stone EM, Tucker BA, Mullins RF.

J Pathol. 2016 Oct;240(2):173-83. doi: 10.1002/path.4766. Epub 2016 Sep 19.

11.

Transcriptome Analysis on Monocytes from Patients with Neovascular Age-Related Macular Degeneration.

Grunin M, Hagbi-Levi S, Rinsky B, Smith Y, Chowers I.

Sci Rep. 2016 Jul 4;6:29046. doi: 10.1038/srep29046.

12.

Genetic Association Analysis of Drusen Progression.

Hoffman JD, van Grinsven MJ, Li C, Brantley M Jr, McGrath J, Agarwal A, Scott WK, Schwartz SG, Kovach J, Pericak-Vance M, Sanchez CI, Haines JL.

Invest Ophthalmol Vis Sci. 2016 Apr 1;57(4):2225-31. doi: 10.1167/iovs.15-18571.

13.

Drusen volume development over time and its relevance to the course of age-related macular degeneration.

Schlanitz FG, Baumann B, Kundi M, Sacu S, Baratsits M, Scheschy U, Shahlaee A, Mittermüller TJ, Montuoro A, Roberts P, Pircher M, Hitzenberger CK, Schmidt-Erfurth U.

Br J Ophthalmol. 2017 Feb;101(2):198-203. doi: 10.1136/bjophthalmol-2016-308422. Epub 2016 Apr 4.

15.

Gene-Based Association Analysis for Censored Traits Via Fixed Effect Functional Regressions.

Fan R, Wang Y, Yan Q, Ding Y, Weeks DE, Lu Z, Ren H, Cook RJ, Xiong M, Swaroop A, Chew EY, Chen W.

Genet Epidemiol. 2016 Feb;40(2):133-43. doi: 10.1002/gepi.21947. Epub 2016 Jan 18.

16.

Adherence to a Mediterranean diet, genetic susceptibility, and progression to advanced macular degeneration: a prospective cohort study.

Merle BM, Silver RE, Rosner B, Seddon JM.

Am J Clin Nutr. 2015 Nov;102(5):1196-206. doi: 10.3945/ajcn.115.111047. Epub 2015 Oct 21.

17.

CX3CR1 polymorphisms and the risk of age-related macular degeneration.

Ma B, Dang G, Yang S, Duan L, Zhang Y.

Int J Clin Exp Pathol. 2015 Aug 1;8(8):9592-6. eCollection 2015.

18.

Impairments in Dark Adaptation Are Associated with Age-Related Macular Degeneration Severity and Reticular Pseudodrusen.

Flamendorf J, Agrón E, Wong WT, Thompson D, Wiley HE, Doss EL, Al-Holou S, Ferris FL 3rd, Chew EY, Cukras C.

Ophthalmology. 2015 Oct;122(10):2053-62. doi: 10.1016/j.ophtha.2015.06.023. Epub 2015 Aug 4.

19.

Differences in the Genetic Susceptibility to Age-Related Macular Degeneration Clinical Subtypes.

Shen L, Hoffmann TJ, Melles RB, Sakoda LC, Kvale MN, Banda Y, Schaefer C, Risch N, Jorgenson E.

Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4290-9. doi: 10.1167/iovs.15-16533.

20.

Identification of Drusen Characteristics in Age-Related Macular Degeneration by Polarization-Sensitive Optical Coherence Tomography.

Schlanitz FG, Sacu S, Baumann B, Bolz M, Platzer M, Pircher M, Hitzenberger CK, Schmidt-Erfurth U.

Am J Ophthalmol. 2015 Aug;160(2):335-344.e1. doi: 10.1016/j.ajo.2015.05.008. Epub 2015 May 15.

Supplemental Content

Support Center